BOSTON, June 06, 2025 (GLOBE NEWSWIRE) -- Rectify Pharmaceuticals, Inc., (“Rectify”) a biotechnology company pioneering positive functional modulators (PFMs) that restore and enhance membrane protein ...
Potent, selective ABCC6-targeting positive functional modulator (PFM) improved multiple markers of renal function in animal models of chronic kidney disease (CKD) PFM improved inorganic pyrophosphate ...
The translational readiness of this program makes it a compelling de-risked asset with the potential to address CKD and multiple cardiovascular indications.” Title: A Positive Functional Modulator of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback